25Serious

Carlos Gómez

Carlos Gómez

Ask VT AI

View News Summary

Trump rules out 2028 vice presidential run, but leaves open possibility of another presidential term.
Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Trump rules out 2028 vice presidential run, but leaves open possibility of another presidential term.
Milei's party projected to maintain veto power in Argentina's midterm elections, with gains in both chambers of Congress.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Carlos Gómez